The use of infliximab in South-east Asian children with severe Crohn's disease
Childhood Crohn's disease (CD) has a chronic relapsing course with a high morbidity which includes delayed puberty, impaired growth, and perianal disease1. It is most prevalent in North America, North-west Europe, and in the United Kingdom, and is rare in Asia1. Many children with CD eventually...
| Main Author: | |
|---|---|
| Format: | Article |
| Published: |
2004
|
| Subjects: |